The introduction of the drug in the country is sparking significant excitement within the medical community. This novel dual compound – acting on both GLP-1 and GIP receptors – offers a remarkably powerful approach https://australianpeptidestore.co/bpc-157-10mg-research-peptide-australian-peptide-store/